CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity

Abstract

CARM1 is an arginine methyltransferase that asymmetrically dimethylates protein substrates on arginine residues. CARM1 is often overexpressed in human cancers. However, clinically applicable cancer therapeutic strategies based on CARM1 expression remain to be explored. Here, we report that EZH2 inhibition is effective in CARM1-expressing epithelial ovarian cancer. Inhibition of EZH2 activity using a clinically applicable small molecule inhibitor significantly suppresses the growth of CARM1-expressing, but not CARM1-deficient, ovarian tumors in two xenograft models and improves the survival of mice bearing CARM1-expressing ovarian tumors. The observed selectivity correlates with reactivation of EZH2 target tumor suppressor genes in a CARM1-dependent manner. Mechanistically, CARM1 promotes EZH2-mediated silencing of EZH2/BAF155 target tumor suppressor genes by methylating BAF155, which leads to the displacement of BAF155 by EZH2. Together, these results indicate that pharmacological inhibition of EZH2 represents a novel therapeutic strategy for CARM1-expressing cancers.

RETRACTED ARTICLE: Curcumin inhibits the migration of osteoclast precursors and osteoclastogenesis by repressing CCL3 production

“…The recombinant lentivirus encoding the CCR1 cDNA (LV-CCR1), and the control vectors (LV-Cont) were constructed using the lentivirus construction kit in 293 cells as previously described (GeneCopoeia; Washington, Maryland, USA) [ 29 ]. After 2 days, the supernatants were collected and cells were incubated in medium containing lentivirus and polybrene (7.5 μg/ml) at multiplicity of infection (MOI) 10.…”

GAPDH Overexpression in the T Cell Lineage Promotes Angioimmunoblastic T Cell Lymphoma through an NF-κB-Dependent Mechanism

“…EZH2 is increasingly expressed during the progression of hematopoietic and solid cancers (Bachmann et al, 2006;Chen et al, 2018;Karakashev et al, 2018;Patnaik et al, 2018;Sudo et al, 2005), and overexpression of mutant EZH2 has been recognized in a wide selection of B and T cell lymphoproliferative disorders (Morin et al, 2010;Raaphorst et al, 2000;Sasaki et al, 2011;Sneeringer et al, 2010;Visser et al, 2001). Therefore, considerable effort has been directed toward development of EZH2 inhibitors, but current specific EZH2 inhibitors can (B) GSEA for the NF-kB related genes in (A).…”

DJ‐1 inhibits autophagy activity of prostate cancer cells by repressing JNK–Bcl2–Beclin1 signaling

“…Recombinant lentiviruses encoding the DJ‐1 cDNA or shRNA against DJ‐1 , and the corresponding control vectors were constructed by homologous recombination between the expression vector (EX‐Puro‐Lv105) and cDNA in 293 cells as previously described using the lentiviral construction kit (GeneCopoeia, Washington, MD, USA) (Karakashev et al, ). After 2 days, the supernatants were collected and LNCaP incubated in the medium containing lentiviruses and 8 μg/mL polybrene at multiplicity of infection 30 for 5 days.…”